Value Bridge — GEISINGER MEDICAL CENTER
Current $65M → Target $100M (+$35.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$65.4M
Current EBITDA
$100.3M
Target EBITDA
+$35.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$7.9M
Payer Mix Optimization
$19.0M
Cost to Collect Reduction
$6.3M
Clean Claim Improvement
$4.7M
Volume & Rate Growth
$31.7M
What This Means
The 7-lever model projects a 54% EBITDA uplift from $65M to $100M. The highest-impact lever is Volume & Rate Growth at $12.7M probability-weighted.
IC talking point: "We see $35M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $385M in equity value creation."